| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | John A Hamilton | |
| P2860 | cites work | Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation | Q80088055 |
| Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation | Q80597396 | ||
| Sca-1+ cardiac fibroblasts promote development of heart failure | Q89312939 | ||
| Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function | Q89776979 | ||
| Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model | Q91451190 | ||
| GM-CSF- and IRF4-Dependent Signaling Can Regulate Myeloid Cell Numbers and the Macrophage Phenotype during Inflammation | Q93110181 | ||
| Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch | Q24302076 | ||
| The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation | Q24322589 | ||
| Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology | Q24562866 | ||
| Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling | Q27718099 | ||
| IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses | Q28303437 | ||
| Negative regulation of Toll-like-receptor signaling by IRF-4. | Q28587563 | ||
| Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. | Q30156952 | ||
| GM-CSF and IL-3 Modulate Human Monocyte TNF-α Production and Renewal in In Vitro Models of Trained Immunity. | Q30835058 | ||
| Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization | Q31040402 | ||
| GM-CSF produced by the airway epithelium is required for sensitization to cockroach allergen | Q33559067 | ||
| Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis | Q33703008 | ||
| Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. | Q33826888 | ||
| GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. | Q33839932 | ||
| Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency | Q33881232 | ||
| Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells | Q33949038 | ||
| Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development | Q34049333 | ||
| Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS | Q34115841 | ||
| Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival | Q34633876 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. | Q34660473 | ||
| GM-CSF in inflammation and autoimmunity. | Q34754737 | ||
| The closely related CD103+ dendritic cells (DCs) and lymphoid-resident CD8+ DCs differ in their inflammatory functions | Q35122681 | ||
| Innate response activator B cells protect against microbial sepsis. | Q35757819 | ||
| Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. | Q36131723 | ||
| Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis | Q36356742 | ||
| GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells | Q36398839 | ||
| ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation | Q36520874 | ||
| GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival | Q36916371 | ||
| Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells | Q37086985 | ||
| Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. | Q37151168 | ||
| Colony-stimulating factors in inflammation and autoimmunity. | Q37190439 | ||
| Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization | Q37193358 | ||
| Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. | Q37194936 | ||
| Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation | Q37217530 | ||
| The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells. | Q50795170 | ||
| Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation. | Q51661405 | ||
| CCL17 blockade as a therapy for osteoarthritis pain and disease. | Q52604134 | ||
| TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17. | Q52644010 | ||
| GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis. | Q53068398 | ||
| The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity. | Q53820832 | ||
| Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis. | Q55431503 | ||
| Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models | Q57149911 | ||
| Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis | Q57791844 | ||
| The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2 | Q58566120 | ||
| GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function | Q58698466 | ||
| Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis | Q61955107 | ||
| Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs | Q61955184 | ||
| Can DCs be distinguished from macrophages by molecular signatures? | Q64447023 | ||
| Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity | Q70400790 | ||
| Stimulation of macrophage plasminogen activator activity by colony-stimulating factors | Q72078052 | ||
| Coordinate and noncoordinate colony stimulating factor formation by human monocytes | Q72273937 | ||
| Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation | Q77698627 | ||
| GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease | Q37272083 | ||
| GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. | Q37300266 | ||
| GM-CSF Grown Bone Marrow Derived Cells Are Composed of Phenotypically Different Dendritic Cells and Macrophages. | Q37408243 | ||
| Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation | Q37466119 | ||
| Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. | Q37730878 | ||
| Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. | Q37734578 | ||
| Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy | Q37983043 | ||
| Colony stimulating factors and myeloid cell biology in health and disease. | Q38045643 | ||
| The transcriptional regulator network of human inflammatory macrophages is defined by open chromatin. | Q38299850 | ||
| Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages | Q38319108 | ||
| GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential. | Q38369816 | ||
| GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage. | Q38598045 | ||
| Targeting GM-CSF in inflammatory diseases | Q38657999 | ||
| GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation | Q39010211 | ||
| Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases | Q39056339 | ||
| Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers | Q39578612 | ||
| The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells | Q40172102 | ||
| The nature and action of granulocyte-macrophage colony stimulating factors | Q40294239 | ||
| Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways. | Q40697788 | ||
| GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. | Q40826938 | ||
| Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. | Q40891825 | ||
| Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation | Q41079801 | ||
| Analysis of the developmental stages, kinetics, and phenotypes exhibited by myeloid cells driven by GM-CSF in vitro. | Q41153792 | ||
| Specific Contributions of CSF-1 and GM-CSF to the Dynamics of the Mononuclear Phagocyte System. | Q41198470 | ||
| CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor | Q41578750 | ||
| Targeting cholesterol homeostasis in lung diseases | Q41581562 | ||
| Th1 is the predominant helper T cell subset that produces GM-CSF in the joint of rheumatoid arthritis | Q41687192 | ||
| Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. | Q41921955 | ||
| Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages. | Q43103557 | ||
| GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. | Q43774205 | ||
| Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. | Q45296517 | ||
| Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System | Q46413912 | ||
| The Cytokine TGF-β Promotes the Development and Homeostasis of Alveolar Macrophages | Q47415620 | ||
| Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor | Q47677644 | ||
| The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes | Q47696973 | ||
| Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes | Q47848263 | ||
| Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. | Q48509512 | ||
| IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. | Q48708663 | ||
| Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab | Q49393096 | ||
| The Activin A-Peroxisome Proliferator-Activated Receptor Gamma Axis Contributes to the Transcriptome of GM-CSF-Conditioned Human Macrophages. | Q49779441 | ||
| Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity. | Q49958889 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 2055 | |
| P577 | publication date | 2019-09-04 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | GM-CSF-Dependent Inflammatory Pathways | |
| P478 | volume | 10 |
| Q93229804 | A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection |
| Q98177702 | Csf2 Attenuated Sepsis-Induced Acute Kidney Injury by Promoting Alternative Macrophage Transition |
| Q98657521 | GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study |
| Q99590940 | Host Immune Defense upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions as Drivers of Inflammatory Responses |
| Q89621250 | Immunobiology of Cervix Ripening |
| Q90364705 | Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation? |
| Q100526688 | The efficacy and safety of targeting GM-CSF in arthritis |
| Q99400656 | The role of Interleukin 6 inhibitors in therapy of severe COVID-19 |
| Q96591069 | Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities |
Search more.